Veru Inc (VERU) reports positive Phase 2B study results for Novosarm, but faces financial hurdles with a net loss and need ...

Q2 2025 Management View CEO Mitchell Steiner emphasized Veru’s focus on its obesity program, highlighting the positive Phase 2b clinical trial results for enobosarm. This drug, when combined with ...

Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of calendar 2025 -- --With positive Phase 2b QUALITY study, Veru plans for end of Phase 2 ...

Data from the recently completed 4-week study in diet-induced obese mice show a 26% reduction in fat mass following treatment with the Activin E antibody, with muscle mass fully preserved.

Research shows belly fat accumulation is linked to aging cells, not just sedentary lifestyle choices. Stem cells transform ...

But BMI doesn't tell the whole story. For example, someone with high muscle mass—like an athlete—might have a high BMI but low body fat. On the flip side, someone with a normal BMI could still ...

New research suggests that weight loss treatments using GLP-1 and dual GLP-1/GIP receptor agonists can lead to significant fat loss while still maintaining lean muscle mass. The study found that ...

Smart scales can help you keep track of your muscle mass, body fat percentage, bone density and other health stats — these are the best models we have tested. The best smart scales do far more ...

Body Mass Index (BMI): What It Tells You — And What It Doesn’t SUNDAY, May 4, 2025 (HealthDay News) — Body Mass Index, or BMI, is a number that reflects the relationship between your height ...